Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc (TARS) Option Chain
As of September 21, 2026, Tarsus Pharmaceuticals Inc is trading at $77.46, a -0.81% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 58.4%. IV Rank is 36%.
Read more
Tracking the TARS option chain helps you see every strike and expiry on Tarsus Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Tarsus Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TARS options activity at a glance. Use our scanner to monitor the TARS option chain in real time and filter for the TARS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TARS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TARS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TARS stock options are being actively traded and where they are not.
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases.
Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Tarsus Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TARS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TARS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile19.44% Subdued
- Market cap (M$)3,624
- 52 weeks high-15.37%
- 52 weeks low43.84%
- Analyst recommendationStrong Buy
1.10 - Target price$98.22
26.80% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E51.47
- EPS (ttm)-1.08
- EPS growth next 5 years—
As of September 21, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 19.84 | 1 | 0 | 1.74 | 9.96 | 9.40 | 14.00 | 67.50 | -12.86 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 80.16 |
| 27.16 | 0 | 0 | 2.44 | 7.46 | 7.80 | 12.00 | 70.00 | -9.63 | 0.10 | 4.90 | 0.00 | 2.50 | 0 | 35 | 72.84 |
| 43.88 | 1,007 | 0 | 3.84 | 2.46 | 4.00 | 8.60 | 75.00 | -3.18 | 1.50 | 6.20 | 0.00 | 3.85 | 0 | 0 | 56.12 |
| 60.66 | 9 | 0 | 3.00 | 0.00 | 1.50 | 4.50 | 80.00 | +3.28 | 4.00 | 7.00 | 2.54 | 2.96 | 0 | 3 | 39.34 |
| 74.84 | 21 | 0 | 4.90 | 0.00 | — | 4.90 | 85.00 | +9.73 | 7.00 | 11.80 | 7.54 | 1.86 | 0 | 1 | 25.16 |
As of September 21, 2026
Scan the full option chain in one place
Browse the full TARS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→